Weight Loss Medications in Young Adults after Bariatric Surgery for Weight Regain or Inadequate Weight Loss: A Multi-Center Study
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
This paper presents a retrospective cohort study of weight loss medications in young adults aged 21 to 30 following Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) between November 2000 and June 2014. Data were collected from patients who used topiramate, phentermine, and/or metformin postoperatively. Percentage of patients achieving ≥5%, ≥10%, or ≥15% weight loss on medications was determined and percent weight change on each medication was compared to percent weight change of the rest of the cohort. Our results showed that 54.1% of study patients lost ≥5% of their postsurgical weight; 34.3% and 22.9% lost ≥10% and ≥15%, respectively. RYGB had higher median percent weight loss (−8.1%) than SG (−3.3%) (p = 0.0515). No difference was found in median percent weight loss with medications started at weight plateau (−6.0%) versus after weight regain (−5.4%) (p = 0.5304). Patients taking medications at weight loss plateau lost 41.2% of total body weight from before surgery versus 27.1% after weight regain (p = 0.076). Median percent weight change on metformin was −2.9% compared to the rest of the cohort at −7.7% (p = 0.0241). No difference from the rest of the cohort was found for phentermine (p = 0.2018) or topiramate (p = 0.3187). Topiramate, phentermine, and metformin are promising weight loss medications for 21 to 30 year olds. RYGB patients achieve more weight loss on medications but both RYGB and SG benefit. Median total body weight loss from pre-surgical weight may be higher in patients that start medication at postsurgical nadir weight. Participants on metformin lost significantly smaller percentages of weight on medications, which could be the result of underlying medical conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“research that examined the use of topiramate, phentermine, and/or metformin among young adults with WR found that 54.1%, 34.3%, and 22.9% of the sample lost ≥ 5%, ≥ 10%, and ≥ 15% of their postsurgical weight, respectively, and those who used metformin demonstrated the highest percent weight change compared to the other medications [96].”
In the citing paper
“patients who underwent RYGB achieved significantly higher TWL% compared to those who underwent LSG (− 8.1% vs − 3.3%) [96].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bariatric Surgery: A Systematic Review and Meta-analysis
Buchwald, H., Avidor, Y., Braunwald, E., Jensen, M. D., Pories, W., Fahrbach, K., & Schoelles, K. (2004) · JAMA · doi:10.1001/jama.292.14.1724 · Cited by 6,800
Chang, S.-H., Stoll, C. R. T., Song, J., Varela, J. E., Eagon, C. J., & Colditz, G. A. (2014) · JAMA Surgery · doi:10.1001/jamasurg.2013.3654 · Cited by 1,688
Sjöström, L., Peltonen, M., Jacobson, P., Ahlin, S., Andersson-Assarsson, J., Anveden, Å., Bouchard, C., Carlsson, B., Karason, K., Lönroth, H., et al. (2014) · JAMA · doi:10.1001/jama.2014.5988 · Cited by 1,054
Systematic review on reoperative bariatric surgery
Brethauer, S. A., Kothari, S., Sudan, R., Williams, B., English, W. J., Brengman, M., Kurian, M., Hutter, M., Stegemann, L., Kallies, K., et al. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.02.014 · Cited by 392 · cited 1×
“Surgical revisions may be attempted and have occasionally demonstrated improvements in obesity co-morbidities and weight loss, however, the risk of complications with revision procedures is significantly higher than with initial bariatric surgery [7,8].”
BackgroundTrends in weight regain following roux-en-Y gastric bypass (RYGB) bariatric surgery
Cooper, T. C., Simmons, E. B., Webb, K., Burns, J. L., & Kushner, R. F. (2015) · Obesity Surgery · doi:10.1007/s11695-014-1560-z · Cited by 305 · cited 1×
“Additionally, studies have shown that significant weight regain occurs in 25–35% of people who have bariatric surgery within 2–5 years of their procedure [11,12].”
BackgroundRe-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up
DiGiorgi, M., Rosen, D. J., Choi, J. J., Milone, L., Schrope, B., Olivero-Rivera, L., Restuccia, N., Yuen, S., Fisk, M., Inabnet, W. B., et al. (2010) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2009.09.019 · Cited by 282 · cited 1×
“Unfortunately, co-morbidities often return with weight regain [5,6].”
BackgroundEffectiveness of Metformin on Weight Loss in Non-Diabetic Individuals with Obesity
Seifarth, C., Schehler, B., & Schneider, H. (2012) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0032-1327734 · Cited by 258 · cited 1×
“Metformin has shown success in trials for weight loss in patients without diabetes [25] and may decrease appetite and oppose unfavorable fat storage in peripheral tissues [26].”
BackgroundEffects of metformin on weight loss: potential mechanisms
Malin, S. K., & Kashyap, S. R. (2014) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000095 · Cited by 223 · cited 1×
“Metformin has shown success in trials for weight loss in patients without diabetes [25] and may decrease appetite and oppose unfavorable fat storage in peripheral tissues [26].”
BackgroundStanford, F. C., Alfaris, N., Gomez, G., Ricks, E. T., Shukla, A. P., Corey, K. E., Pratt, J. S., Pomp, A., Rubino, F., & Aronne, L. J. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.10.018 · Cited by 206 · cited 7×
“Despite these limitations, our study data came from two large academic study sites performing the two most common weight loss procedures in the United States and included a long duration of follow up, which gave us insight into the long-term successes achievable in young adults using weight loss medication after baria…”
MethodResultInfluentialSelf-citationBariatric Surgery: A Systematic Review of the Clinical and Economic Evidence
Padwal, R., Klarenbach, S., Wiebe, N., Hazel, M., Birch, D., Karmali, S., Sharma, A. M., Manns, B., & Tonelli, M. (2011) · Journal of General Internal Medicine · doi:10.1007/s11606-011-1721-x · Cited by 204 · cited 1×
“It has also been previously observed that RYGB patients have a higher likelihood of weight loss compared to patients who undergo SG [17,22].”
Resultfor the Diabetes Prevention Program Research Group, Aroda, V. R., Knowler, W. C., Crandall, J. P., Perreault, L., Edelstein, S. L., Jeffries, S. L., Molitch, M. E., Pi-Sunyer, X., Darwin, C., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4361-9 · Cited by 194 · cited 1×
“Metformin is a well-tested, safe drug for use in diabetes treatment and for the prevention of diabetes in cases of pre-diabetes [24].”
BackgroundTotal Weight Loss as the Outcome Measure of Choice After Roux-en-Y Gastric Bypass
Corcelles, R., Boules, M., Froylich, D., Hag, A., Daigle, C. R., Aminian, A., Brethauer, S. A., Burguera, B., & Schauer, P. R. (2016) · Obesity Surgery · doi:10.1007/s11695-015-2022-y · Cited by 170 · cited 1×
“It is unknown whether differences in response to weight loss medications exist in younger and older adults [19].”
BackgroundTrifiro, G., & Spina, E. (2011) · Current Drug Metabolism · doi:10.2174/138920011796504473 · Cited by 157 · cited 1×
“Differences in responses to both psychotropic and cardiovascular drugs have been observed in older adults compared to younger adults [18].”
Systematic Review of Definitions of Failure in Revisional Bariatric Surgery
Mann, J. P., Jakes, A. D., Hayden, J. D., & Barth, J. H. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1541-2 · Cited by 143 · cited 1×
“Following surgery, patients often experience complete or partial resolution of obesity-related co-morbidities with weight loss, but may struggle with inadequate weight loss or weight regain [4].”
BackgroundInfluentialPredictors of weight regain in patients who underwent Roux-en-Y gastric bypass surgery
Shantavasinkul, P. C., Omotosho, P. A., Corsino, L., Portenier, D. D., & Torquati, A. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.08.028 · Cited by 137 · cited 2×
“All but four patients achieved greater than 20% of total body weight loss, which has been used as a weight loss metric for success of bariatric surgery [20].”
BackgroundResultFatores determinantes do reganho ponderal no pós-operatório de cirurgia bariátrica
Bastos, E. C. L., Barbosa, E. M. W. G., Soriano, G. M. S., Santos, E. A. D., & Vasconcelos, S. M. L. (2013) · ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) · doi:10.1590/s0102-67202013000600007 · Cited by 125 · cited 1×
“Additionally, studies have shown that significant weight regain occurs in 25–35% of people who have bariatric surgery within 2–5 years of their procedure [11,12].”
BackgroundTratamento de curto prazo com liraglutide no reganho de peso após cirurgia bariátrica
Pajecki, D., Halpern, A., Cercato, C., Mancini, M., Cleva, R. D., & Santo, M. A. (2013) · Revista do Colégio Brasileiro de Cirurgiões · doi:10.1590/s0100-69912013000300005 · Cited by 93
Efficacy of adjuvant weight loss medication after bariatric surgery
Nor Hanipah, Z., Nasr, E. C., Bucak, E., Schauer, P. R., Aminian, A., Brethauer, S. A., & Cetin, D. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2017.10.002 · Cited by 93 · cited 2×
“This finding agrees with recent findings by Nor Hanipah and colleagues that found response to weight loss medications to be significantly better in RYGB and gastric banding patients compared to SG patients [14].”
BackgroundResultRyder, J. R., Gross, A. C., Fox, C. K., Kaizer, A. M., Rudser, K. D., Jenkins, T. M., Ratcliff, M. B., Kelly, A. S., Kirk, S., Siegel, R. M., et al. (2018) · International Journal of Obesity · doi:10.1038/ijo.2017.193 · Cited by 85 · cited 2×
“Ryder and colleagues used a cut off of 20% at 5 years to group patients that had maintained postsurgical weight loss or regained weight [21].”
BackgroundSchwartz, J., Suzo, A., Wehr, A. M., Foreman, K. S., Mikami, D. J., Needleman, B. J., & Noria, S. F. (2016) · Obesity Surgery · doi:10.1007/s11695-015-1979-x · Cited by 84
Neto, R. M. L., Herbella, F. A. M., Tauil, R. D. M., Silva, F. S., & de Lima, S. E. (2012) · Obesity Surgery · doi:10.1007/s11695-012-0731-z · Cited by 77 · cited 1×
“Unfortunately, co-morbidities often return with weight regain [5,6].”
BackgroundA comparison of revisional and primary bariatric surgery
Fulton, C., Sheppard, C., Birch, D., Karmali, S., & de Gara, C. (2017) · Canadian Journal of Surgery · doi:10.1503/cjs.006116 · Cited by 65 · cited 1×
“Surgical revisions may be attempted and have occasionally demonstrated improvements in obesity co-morbidities and weight loss, however, the risk of complications with revision procedures is significantly higher than with initial bariatric surgery [7,8].”
BackgroundHormone Changes Affecting Energy Homeostasis after Metabolic Surgery
Harvey, E. J., Arroyo, K., Korner, J., & Inabnet, W. B. (2010) · Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20203 · Cited by 59 · cited 1×
“Differences in the two surgeries and the physiologic changes that occur in the two may explain varying responses to different weight loss medications [23].”
BackgroundZilberstein, B., Pajecki, D., de Brito, A. C. G., Gallafrio, S. T., Eshkenazy, R., & Andrade, C. G. (2004) · Obesity Surgery · doi:10.1381/0960892041590926 · Cited by 58 · cited 1×
“While alternative surgical solutions for weight regain or inadequate weight loss exist, they do not prove to be sufficient long-term solutions [9,10].”
BackgroundSrivastava, G., & Buffington, C. K. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3141-z · Cited by 51
Jester, L., Wittgrove, A. C., & Clark, G. W. (1996) · Obesity Surgery · doi:10.1381/096089296765556476 · Cited by 38
Cited by
El Ansari, W., & Elhag, W. (2021) · Obesity Surgery · doi:10.1007/s11695-020-05160-5 · Cited by 482
“5%, ≥ 10%, and ≥ 15% of their postsurgical weight, respectively, and those who used metformin demonstrated the highest percent weight change compared to the other medications [96].”
BackgroundBenefits of weight loss of 10% or more in patients with overweight or obesity: A review
Tahrani, A. A., & Morton, J. (2022) · Obesity · doi:10.1002/oby.23371 · Cited by 125
“For the remaining publications identified by our searches, the weight- loss intervention was classified as “multiple” (n = 3) (17,47,60), “unknown” (n = 1 study that could not distinguish between intentional and unintentional weight loss) (34), or “none” (n = 1 modeling study) (46).”
BackgroundApproach to the Patient: Management of the Post–Bariatric Surgery Patient With Weight Regain
Istfan, N. W., Lipartia, M., Anderson, W. A., Hess, D. T., & Apovian, C. M. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa702 · Cited by 83
Ahmad, N. N., Robinson, S., Kennedy‐Martin, T., Poon, J. L., & Kan, H. (2021) · Obesity Reviews · doi:10.1111/obr.13326 · Cited by 69
Czepiel, K. S., Perez, N. P., Campoverde Reyes, K. J., Sabharwal, S., & Stanford, F. C. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00290 · Cited by 69
Self-citation
Metadata
- Authors
- Toth, A. T., Gomez, G., Shukla, A. P., Pratt, J. S., Cena, H., Biino, G., Aronne, L. J., & Stanford, F. C.
- Affiliations
- Massachusetts General Hospital (US)
- Department of Surgery-Urology, Brigham and Women’s Hospital, Boston, MA 02115, USA
- Weill Cornell Medicine (US)
- Lucile Packard Children's Hospital (US)
- University of Pavia (IT)
- National Research Council (IT)
- Harvard University (US)
- Corresponding author
- Stanford, Fatima Cody
- ORCID
- Venue
- Children
- Publisher
- MDPI AG
- Published
- 2018-08-29
- Volume
- 5
- Issue
- 9
- Pages
- 116
- ISSN
- 2227-9067 (ISSN-L)
- PMC
- PMC6162731
- OpenAlex
- W2889515720
- Cited by
- 57
- References
- 26
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 13 · 2023: 6 · 2022: 6 · 2021: 9 · 2020: 8 · 2019: 5 · 2018: 1
- FWCI
- 5.98
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Children (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (R01 DK103946-01A1, P30 DK040561)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Health Sciences › Medicine › Surgery › Body Contouring and Surgery
- Keywords
- anti-obesity drugs, bariatric surgery, Roux-en-Y gastric bypass, sleeve gastrectomy, young adults, weight regain, topiramate, phentermine, metformin, postoperative weight loss
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
